(PatriotNewsDaily.com) – Ozempic and Saxenda, created by Novo Nordisk in Denmark, are popular medications for diabetes and weight loss. However, recent reports from the European Medicines Agency (EMA) have pointed out that there has been a small number of instances where users of the drugs have expressed self-harm and suicidal thoughts.
According to the EU’s safety review, there have been reports about three people, all located in Iceland, two of whom take Ozempic and one who is on Saxenda expressing suicidal thoughts or self-harm thoughts. The two drugs are considered glucagon-like peptide 1 (GLP-1) agonists, which means that they can have two effects on the body, the first being controlling the blood sugar levels and the second assisting in weight loss.
Ozempic is specifically meant to be used for type 2 diabetes, while Saxenda, is marketed as a weight-loss pill.
The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is also going to be looking at other GLP-1 medications following these reports. An NYU Langone Medical Center professor of medicine, Dr. Marc Siegel who also works as a medical contributor for Fox News stated that association does not automatically “prove causality.” He added that these findings could also be an indication about the people who are requesting these types of drugs, and it could be indicative of other things they suffer from including obesity, and medical or psychological issues.
He added that it is important that these things be tested further, as this type of medication has an effect on hormones in the brain.
Copyright 2023, PatriotNewsDaily.com